The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension
Stephen Glasser
Clinical Therapeutics, 1995
View PDFchevron_right
The nifedipine gastrointestinal therapeutic system in the treatment of hypertension
John Grundy
The American Journal of Cardiology, 1989
View PDFchevron_right
Antihypertensive effectiveness of the nifedipine gastrointestinal therapeutic system
Rogerio Mulinari
The American Journal of Medicine, 1987
View PDFchevron_right
Short-term efficacy and safety of a single five-milligram dose of oral nifedipine in uncontrolled essential systemic hypertension
ENRIQUE VELAZQUEZ RODRIGUEZ
The American Journal of Cardiology, 1991
View PDFchevron_right
Nifedipine in the treatment of hypertension: report of a double-blind controlled trial
S. Bayley
British Journal of Clinical Pharmacology, 1982
View PDFchevron_right
A review of the gastrointestinal therapeutic system (GITS) formulation and its effectiveness in the delivery of antihypertensive drug treatment (focus on nifedipine GITS)
Dove Medical Press
2013
View PDFchevron_right
Effect of food components and dosing times on the oral pharmacokinetics of nifedipine in rats
Beom-jin Lee
International Journal of Pharmaceutics, 2010
View PDFchevron_right
Long-term therapy with slow-release nifedipine in essential hypertension
Francesco Arrigo
Cardiovascular Drugs and Therapy, 1990
View PDFchevron_right
Acute and sustained changes in sodium balance during nifedipine treatment in essential hypertension
Francesco P Cappuccio
The American Journal of Medicine, 1991
View PDFchevron_right
Pharmacokinetic Study of Nifedipine in Healthy Adult Male Human Volunteers
Ghulam Murtaza
Tropical Journal of Pharmaceutical Research, 2009
View PDFchevron_right
Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study
Masatsugu Horiuchi, Kazuaki Shimamoto, Kenjiro Kimura
Hypertension Research, 2014
View PDFchevron_right
Hemodynamic study of nifedipine administration in hypertensive patients
Nicola Ferrara
American Heart Journal, 1983
View PDFchevron_right
Efficacy and Tolerability of Long-Acting Nifedipine GITS/OROS Monotherapy or Combination Therapy in Hypertensive Patients
Kwo-chang Ueng
Clinical Drug Investigation, 2011
View PDFchevron_right
Formulation of an Oral Controlled Release Dosage Form for Nifedipine
Varun Garg
2020
View PDFchevron_right
Combination therapy with nifedipine GITS 60 mg: subanalysis of a prospective, 12-week observational study (AdADOSE)
Wajid Hussain
Clinical and experimental hypertension (New York, N.Y. : 1993), 2015
View PDFchevron_right
DESIGN AND EVALUATION OF GASTRORETENTIVE NIFEDIPINE FLOATING TABLETS IN THE TREATMENT OF HYPERTENSION
Editor iajps
View PDFchevron_right
Efficacy and safety of two different formulations of nifedipine (GITS) vs slow release microgranules in patients with mild and moderate hypertension
GUSTAVO Aroca
View PDFchevron_right
Long term reduction in sodium balance: possible additional mechanism whereby nifedipine lowers blood pressure
Francesco P Cappuccio
BMJ, 1990
View PDFchevron_right
Effects of Nifedipine during Low, Normal and High Intakes of Sodium in Patients with Essential Hypertension
Gloria Valdes
Clinical science. Supplement (1979), 1982
View PDFchevron_right
Treatment of Hypertension with a Combination of Nifedipine and Atenolol Compared with Atenolol Alone
Amina Krupalija
Drugs, 1988
View PDFchevron_right
Liquid chromatographic assay of nifedipine in human plasma and its application to pharmacokinetic studies
Tawfeeg Al-Najjar
Journal of Pharmaceutical and Biomedical Analysis, 2000
View PDFchevron_right
Effect of nifedipine tablets on ambulatory blood pressure in patients aged <60 and >65 years with systemic hypertension
Kuniaki Otsuka
The American Journal of Cardiology, 1991
View PDFchevron_right
Treatment of Hypertensive Crisis with Intranasal Nifedipine
Jesús López-herce
Critical Care Medicine, 1988
View PDFchevron_right
Long-acting nifedipine in moderate and severe hypertensive patients with serious concomitant diseases
Ehud Grossman
American Heart Journal, 1985
View PDFchevron_right
The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers
Atholl Johnston
British Journal of Clinical Pharmacology, 1986
View PDFchevron_right
Bioavailability and pharamcotherapeutics of nifedipine in human after single oral dose administration
Ghulam Murtaza
Acta Pharmaceutica Sciencia
View PDFchevron_right
Determination of nifedipine in human plasma by solid-phase extraction and high-performance liquid chromatography: validation and application to pharmacokinetic studies
George Horvai
Journal of Pharmaceutical and Biomedical Analysis, 2003
View PDFchevron_right
Single-Dose, Open-Label, One-Way Pharmacokinetic Studies In The Mexican Population To Evaluate The Bioavailability And Food Effect On The Pharmacokinetics Of 30-mg Extended-Release Nifedipine Tablets
Karen Nathalie Geraldo Bastida
Journal of Bioequivalence & Bioavailability, 2021
View PDFchevron_right
Nifedipine in hypertensive emergencies
Dieter Conen
BMJ, 1983
View PDFchevron_right
Hemodynamic and Endocrine Effects of Acute and Chronic Administration of Nifedipine
Jean-louis Chiasson
The Journal of Clinical Pharmacology, 1989
View PDFchevron_right
Examination of two sustained release nifedipine preparations in humans and in pigs
Lloyd Sansom
European Journal of Pharmaceutical Sciences, 1996
View PDFchevron_right